Stay updated with breaking news from Prime Editor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OUP Management Co. LLC bought a new position in Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 121,255 shares of the company’s stock, valued at approximately $2,253,000. Prime Medicine makes up about 3.7% of […]
Prime Medicine’s (NYSEARCA:PRME – Get Rating) lock-up period will end on Tuesday, April 18th. Prime Medicine had issued 10,294,118 shares in its IPO on October 20th. The total size of the offering was $175,000,006 based on an initial share price of $17.00. Shares of the company owned by company insiders and major shareholders will be […]
Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) shares gapped up prior to trading on Tuesday . The stock had previously closed at $13.33, but opened at $13.92. Prime Medicine shares last traded at $13.49, with a volume of 9,634 shares changing hands. Wall Street Analysts Forecast Growth Several equities analysts have commented on PRME shares. […]
Research analysts at Stifel Nicolaus assumed coverage on shares of Prime Medicine (NYSEARCA:PRME – Get Rating) in a note issued to investors on Monday, The Fly reports. The brokerage set a “buy” rating on the stock. Separately, Morgan Stanley reduced their price objective on Prime Medicine from $23.00 to $21.00 and set an “equal weight” […]
Should You Buy or Sell Prime Medicine Stock? Get The Latest PRME Stock Forecast, Price Target, Headlines, Short Interest at MarketBeat.